News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
GRAYZEL DAVID S.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $16.3, valued at
$203.8k
|
|
| 01/05/2023 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 2,654 options to buy
@ $27.03, valued at
$71.7k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 7,317 options to buy
@ $10.93, valued at
$80k
|
|
| 07/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Aerovate Therapeutics, Inc.|
Txns:
| Granted 878,981 preferred shares
@ $1.893, valued at
$1.7M
Granted 6,102,052 preferred shares
@ $1.893, valued at
$11.6M
Granted 25,000 options to buy
@ $14, valued at
$350k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2020 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Sold 1,700,000 shares
@ $18.1, valued at
$30.8M
|
|
| 06/12/2020 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.35, valued at
$52.2k
|
|
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2019 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,100 options to buy
@ $3.69, valued at
$44.6k
|
|
| 04/23/2018 |
4
| GRAYZEL DAVID S. (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Converted 3,181,817 shares
@ $0
Bought 100,000 shares
@ $15, valued at
$1.5M
Converted 7,000,000 preferred shares
@ $0 |
|
|
|